Tevogen Bio Holdings (TVGN) Assets Average (2022 - 2026)

Tevogen Bio Holdings has reported Assets Average for 5 years, with the latest figure at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 23.48% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (up 23.48% YoY), and the FY2025 full-year result was $3.9 million, down 12.52% from the prior year.
• Assets Average for Q1 2026 stood at $4.7 million, up from $4.4 million in the prior quarter.
• The five-year high for Assets Average was $355.8 million in Q4 2022, with the low at $3.3 million in Q2 2024.
• Historically, Assets Average has averaged $100.7 million across 5 years, with a median of $4.7 million in 2026.
• Annual changes were most pronounced in 2024 — Assets Average plunged 97.68% — and 2025, when it rose 25.0%.
• Tevogen Bio Holdings' Assets Average stood at $355.8 million in 2022, then tumbled by 95.52% to $16.0 million in 2023, then tumbled by 75.71% to $3.9 million in 2024, then advanced by 14.52% to $4.4 million in 2025, then advanced by 4.81% to $4.7 million in 2026.
• The last three Assets Average figures came in at $4.7 million (Q1 2026), $4.4 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.